ISPOR 2016 EU – Value Added Medicines

ispor2

Healthcare System Inefficiencies Related To Medicines: Any Potential Room For Improvement?

ispor3

Value Added Medicines: The Need to Establish One Common Terminology for Repurposed Medicines

ispor4

Value Added Medicines: What Value Repurposed Medicines Might Bring to Society?

ispor5

Obstacles for Adoption of Value Added Medicines: Call for Policy Changes for Value Recognition of Repurposed Medicines

Repurposing: a golden opportunity for patient centric health… 6 April 2022 Report shows the future of meeting unmet medical needs relies…
Giving medicines a new life: EU should foster patients’… 30 November 2022 The added value of innovating on existing medicines may be…
Medicines for Europe is part of the REMEDi4ALL consortium!… 2 September 2022 REMEDi4ALL launched yesterday with the aim of making a major…
OPEN LETTER: Members of the European Parliament and EU 27… 8 November 2023 Medicines for Europe, the European association representing generic, biosimilar and…